China’s first counter-sanction on US biotech industry marks a turning point in tech war

China’s first counter-sanction on US biotech industry marks a turning point in tech war

China’s Ministry of Commerce announced on Tuesday the inclusion of a major US biotech company on its “unreliable entity list” while stating that the firm’s “discriminatory measures against Chinese enterprises” harmed the legitimate rights and interests of Chinese companies. Leading American genomic sequencing firm Illumina is the first biotech company on Beijing’s list. More than…

Read More
China’s trade moves against US show it’s ready to fight back but willing to make a deal

China’s trade moves against US show it’s ready to fight back but willing to make a deal

Observers said China’s retaliatory moves in response to US tariffs showed Beijing’s readiness to face escalating trade tensions along with its desire to achieve more at the negotiation table. Analysts said that compared with the immediate relief the US granted to its neighbours by delaying tariffs on Mexican and Canadian goods, Washington might take a…

Read More